Galun, Eithan

RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients

Golan, T., Khvalevsky, E. Z., Hubert, A., Gabai, R. M., Hen, N., Segal, A., Domb, A., Harari, G., David, E. B., Raskin, S., et al. (2015) · Oncotarget

Pancreatic and Hepatic Oncology ResearchRNA Interference and Gene Delivery

Cited by 336

Mutant KRAS is a druggable target for pancreatic cancer

Zorde Khvalevsky, E., Gabai, R., Rachmut, I. H., Horwitz, E., Brunschwig, Z., Orbach, A., Shemi, A., Golan, T., Domb, A. J., Yavin, E., et al. (2013) · Proceedings of the National Academy of Sciences

RNA Interference and Gene DeliveryPancreatic and Hepatic Oncology Research

Cited by 295

Liver regeneration induced by a designer human IL‐6/ sIL‐6R fusion protein reverses severe hepatocellular injury

Galun, E., Zeira, E., Pappo, O., Peters, M., & Rose-John, S. (2000) · The FASEB Journal

Liver physiology and pathologyDrug-Induced Hepatotoxicity and Protection

Cited by 124

Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL-6 trans-signaling

Rosenberg, N., Van Haele, M., Lanton, T., Brashi, N., Bromberg, Z., Adler, H., Giladi, H., Peled, A., Goldenberg, D. S., Axelrod, J. H., et al. (2022) · Journal of Hepatology

Liver physiology and pathologyHepatocellular Carcinoma Treatment and Prognosis

Cited by 72

Early hepatocyte DNA synthetic response posthepatectomy is modulated by IL-6 trans-signaling and PI3K/AKT activation

Nechemia-Arbely, Y., Shriki, A., Denz, U., Drucker, C., Scheller, J., Raub, J., Pappo, O., Rose-John, S., Galun, E., & Axelrod, J. H. (2011) · Journal of Hepatology

Liver physiology and pathologyCytokine Signaling Pathways and Interactions

Cited by 42

The Regenerative Activity of Interleukin-6

Galun, E., & Rose-John, S. (2013) · Methods in Molecular Biology

Cytokine Signaling Pathways and InteractionsLiver physiology and pathology

Cited by 34

Multiple Roles of IL6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis

Shriki, A., Lanton, T., Sonnenblick, A., Levkovitch-Siany, O., Eidelshtein, D., Abramovitch, R., Rosenberg, N., Pappo, O., Elgavish, S., Nevo, Y., et al. (2021) · Cancer Research

Liver physiology and pathologyCytokine Signaling Pathways and Interactions

Cited by 34

Natural Killer Cell-Dependent Anti-Fibrotic Pathway in Liver Injury via Toll-Like Receptor-9

Abu-Tair, L., Axelrod, J. H., Doron, S., Ovadya, Y., Krizhanovsky, V., Galun, E., Amer, J., & Safadi, R. (2013) · PLoS ONE

Liver physiology and pathologyLiver Diseases and Immunity

Cited by 28